Annual Working Capital
-$40.36 M
-$256.52 M-118.67%
December 31, 2023
Summary
- As of February 7, 2025, ATRA annual working capital is -$40.36 million, with the most recent change of -$256.52 million (-118.67%) on December 31, 2023.
- During the last 3 years, ATRA annual working capital has fallen by -$480.73 million (-109.16%).
- ATRA annual working capital is now -109.16% below its all-time high of $440.37 million, reached on December 31, 2020.
Performance
ATRA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$64.12 M
+$21.73 M+25.31%
September 30, 2024
Summary
- As of February 7, 2025, ATRA quarterly working capital is -$64.12 million, with the most recent change of +$21.73 million (+25.31%) on September 30, 2024.
- Over the past year, ATRA quarterly working capital has dropped by -$23.77 million (-58.89%).
- ATRA quarterly working capital is now -114.56% below its all-time high of $440.37 million, reached on December 31, 2020.
Performance
ATRA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ATRA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -118.7% | -58.9% |
| 3 y3 years | -109.2% | -165.6% |
| 5 y5 years | -114.3% | -165.6% |
ATRA Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -114.5% | at low | -122.8% | +25.3% |
| 5 y | 5-year | -109.2% | at low | -114.6% | +25.3% |
| alltime | all time | -109.2% | at low | -114.6% | +25.3% |
Atara Biotherapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$64.12 M(-25.3%) |
| Jun 2024 | - | -$85.86 M(+15.6%) |
| Mar 2024 | - | -$74.26 M(+84.0%) |
| Dec 2023 | -$40.36 M(-118.7%) | -$40.36 M(-201.9%) |
| Sep 2023 | - | $39.61 M(-59.5%) |
| Jun 2023 | - | $97.77 M(-37.5%) |
| Mar 2023 | - | $156.31 M(-27.7%) |
| Dec 2022 | $216.16 M(-22.5%) | $216.16 M(+2.5%) |
| Sep 2022 | - | $210.80 M(-25.1%) |
| Jun 2022 | - | $281.30 M(+32.2%) |
| Mar 2022 | - | $212.83 M(-23.7%) |
| Dec 2021 | $278.83 M(-36.7%) | $278.83 M(-1.6%) |
| Sep 2021 | - | $283.35 M(-6.6%) |
| Jun 2021 | - | $303.50 M(-20.2%) |
| Mar 2021 | - | $380.11 M(-13.7%) |
| Dec 2020 | $440.37 M(+86.4%) | $440.37 M(+45.2%) |
| Sep 2020 | - | $303.38 M(-7.3%) |
| Jun 2020 | - | $327.30 M(+65.6%) |
| Mar 2020 | - | $197.70 M(-16.3%) |
| Dec 2019 | $236.25 M | $236.25 M(-10.1%) |
| Sep 2019 | - | $262.71 M(+49.8%) |
| Jun 2019 | - | $175.34 M(-22.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $225.66 M(-19.8%) |
| Dec 2018 | $281.51 M(+94.8%) | $281.51 M(-18.6%) |
| Sep 2018 | - | $345.98 M(-13.0%) |
| Jun 2018 | - | $397.84 M(+1.3%) |
| Mar 2018 | - | $392.56 M(+171.6%) |
| Dec 2017 | $144.54 M(-42.4%) | $144.54 M(-23.8%) |
| Sep 2017 | - | $189.70 M(-10.1%) |
| Jun 2017 | - | $211.01 M(-7.3%) |
| Mar 2017 | - | $227.51 M(-9.3%) |
| Dec 2016 | $250.88 M(-20.3%) | $250.88 M(-6.6%) |
| Sep 2016 | - | $268.54 M(-7.0%) |
| Jun 2016 | - | $288.88 M(-4.6%) |
| Mar 2016 | - | $302.88 M(-3.8%) |
| Dec 2015 | $314.89 M(+204.8%) | $314.89 M(-5.7%) |
| Sep 2015 | - | $333.79 M(+124.0%) |
| Jun 2015 | - | $148.99 M(-10.3%) |
| Mar 2015 | - | $166.18 M(+60.9%) |
| Dec 2014 | $103.30 M(+105.4%) | $103.30 M(+108.2%) |
| Sep 2014 | - | $49.61 M(-9.8%) |
| Jun 2014 | - | $54.98 M(-7.6%) |
| Mar 2014 | - | $59.50 M(+18.3%) |
| Dec 2013 | $50.28 M(+1610.3%) | $50.28 M |
| Dec 2012 | $2.94 M | - |
FAQ
- What is Atara Biotherapeutics annual working capital?
- What is the all time high annual working capital for Atara Biotherapeutics?
- What is Atara Biotherapeutics annual working capital year-on-year change?
- What is Atara Biotherapeutics quarterly working capital?
- What is the all time high quarterly working capital for Atara Biotherapeutics?
- What is Atara Biotherapeutics quarterly working capital year-on-year change?
What is Atara Biotherapeutics annual working capital?
The current annual working capital of ATRA is -$40.36 M
What is the all time high annual working capital for Atara Biotherapeutics?
Atara Biotherapeutics all-time high annual working capital is $440.37 M
What is Atara Biotherapeutics annual working capital year-on-year change?
Over the past year, ATRA annual working capital has changed by -$256.52 M (-118.67%)
What is Atara Biotherapeutics quarterly working capital?
The current quarterly working capital of ATRA is -$64.12 M
What is the all time high quarterly working capital for Atara Biotherapeutics?
Atara Biotherapeutics all-time high quarterly working capital is $440.37 M
What is Atara Biotherapeutics quarterly working capital year-on-year change?
Over the past year, ATRA quarterly working capital has changed by -$23.77 M (-58.89%)